Google SSO gives you the quickest path into the IIPLA newsroom, your reading access, and member-level continuity across articles. The full login page is still available if you prefer another option.
Universiti Kebangsaan Malaysia recognized for outstanding IP management; Petronas and Monsta Sdn Bhd also honored at AHIN 2026
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
On February 24, 2022, the Delhi High Court Intellectual Property Rights Division Rules, 2022 and the High Court of Delhi Rules Governing Patent Suits, 2022 were published in the Official Gazette. All IPR lawsuits, cases, procedures, or disputes before the IPD of the Delhi High Court are subject to the Rules. According…
On April 21, 2026, China’s Supreme People’s Court (SPC) published its Annual Report on Legal Application Issues in Intellectual Property Cases of Courts Nationwide (2025) (全国法院知识产权案件法律适用问题年度报告（2025）摘要), identifying 45 legal application issues drawn from intellectual property cases concluded by courts at all levels dur…
Stayble Therapeutics AB, a Swedish biotechnology company specializing in injectable treatments for chronic back pain, has called an extraordinary general meeting on May 7 to vote on a proposal for voluntary liquidation. The board's recommendation follows unsuccessful efforts to secure partnerships or financing for its…
A recent report from BakerHostetler underscores the urgent need for US businesses to overhaul their intellectual property strategies in response to the transformative effects of artificial intelligence, evolving social media practices, and significant regulatory changes. The firm’s 2026 IP Perspectives report details…
A Tokyo District Court has sentenced a website owner to 18 months in prison and imposed a fine exceeding $6,000 for publishing spoiler-heavy posts containing extensive plot details and images from the films Godzilla Minus One and the anime series Overlord. The conviction, initiated by complaints from major Japanese co…
Biotechnology company Moderna has agreed to pay up to $2.25 billion to settle patent litigation over technology used in its COVID-19 vaccine, resolving a dispute with Arbutus Biopharma and Genevant Sciences. The lawsuits alleged that Moderna’s vaccine relied on patented lipid nanoparticle delivery systems, a technolog…